Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Essential fatty acid found in fish oil, involve...
Impurity of everolimus
Endogenous steroid hormone involved in immune r...
Trichothecene mycotoxin produced by Fusarium; p...
Vitamin E component
SGLT2 inhibitor
c-MET, Tie-2, VEGFR inhibitor.
A bacteriocin
Purine nucleotide analog, mercaptiopurine prodr...
Endogenous peptide hormone, increases extracell...
Macrolide lactone found in Bugula; TLR4 activat...
Camptothecin derivative; topoisomerase I inhibi...
Polyphenol found in Camilla sinensis; HIV integ...
Nucleoside (adenosine) analog; P2Y12 antagonist...
PI3K inhibitor.
AR antagonist.
KRAS inhibitor
Carbapenem β-lactam; penicillin binding protei...
Cyclosporin metabolite; weak calmodulin inhibit...
Non-selective HDAC inhibitor.